Pulmonx Corp — Director's Dealing 2020

Oct 7, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2020-10-05

Reporting Person: Lehman David Aaron (General Counsel)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$19.00	2030-09-29	Common Stock (125000)		Direct

Footnotes

F1: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of September 30, 2020, and 1/36th of the remaining shares subject to the option vesting each month thereafter, subject to the Reporting Person's continuous service through each such vesting date.